Proteolysis in human breast cancer
- 1 April 2000
- journal article
- research article
- Published by BMJ in Molecular Pathology
- Vol. 53 (2) , 99-106
- https://doi.org/10.1136/mp.53.2.99
Abstract
Background—The process of proteolysis is important at several stages of the metastatic cascade. A balance between the expression of the genes encoding endogenous proteinases and inhibitors exists and when the production of proteinases exceeds that of inhibitors proteolysis occurs.Keywords
This publication has 26 references indexed in Scilit:
- Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancerBritish Journal of Cancer, 1998
- Metalloproteinase inhibitors and the prevention of connective tissue breakdownPharmacology & Therapeutics, 1996
- [The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis].1995
- Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomasBritish Journal of Cancer, 1994
- [1] Classification of peptidasesPublished by Elsevier ,1994
- Expression of activated gelatinase in human invasive breast carcinomaClinical & Experimental Metastasis, 1993
- Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology.1993
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992
- Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology.1992
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981